Pancreazim 10000
№ 20, № 50
Pharmacotherapeutic group
Active ingredient
Pancreatin
Pharmaceutical form
Enterosoluble tablets
ATC code
А09АА02
RX/OTC
OTC
General properties
Pharmacotherapeutic group
Alimentary tract and metabolism. Digestives, including enzymes. Multienzymes (lipase, protease etc.).
Therapeutic indications
- Diseases associated with impaired digestion due to deficient exocrine pancreatic secretion, such as chronic pancreatitis.
- Conditions after simultaneous resection of the stomach and small intestine, functional accelerated passage of food through the intestines, bowel disorders, simultaneous use of hard-to-digest vegetable, fatty and unusual foods.
- Flatulence and preparation for X-ray or ultrasound diagnostic tests.
Contraindications
Hypersensitivity to the active substance or to any of the drug components. Acute pancreatitis, chronic pancreatitis in its acute stage, obstructing adhesion.
Pharmaceutical characteristics
Main physicochemical properties
Pink, round, biconvex, coated tablets with a slight characteristic odour. When viewed through a magnifying glass a core surrounded by a solid layer is visible upon fracture.
Shelf life
2 years.
Storage
Store in the original packaging below 30 ºС.
Keep away from children.
Manufacturer
PJSC «Technolog».
Location
Building 8, Stara Prorizna Street, Uman City Cherkasy region, 20300, Ukraine.
